Lantern Pharma Inc.
LTRN
$2.51
$0.4521.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -57.86% | -55.93% | -52.19% | -48.59% | -41.86% |
| Total Receivables | -69.07% | -- | -- | -- | -88.72% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.55% | -21.96% | -14.94% | -18.25% | -73.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -56.09% | -69.92% | -60.64% | 32.63% | -- |
| Total Current Assets | -57.21% | -55.01% | -51.26% | -47.24% | -41.75% |
|
|
|||||
| Total Current Assets | -57.21% | -55.01% | -51.26% | -47.24% | -41.75% |
| Net Property, Plant & Equipment | -62.60% | -61.53% | -30.57% | -0.55% | 2.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 241.14% | 0.00% | 14.69% | 41.70% | 41.70% |
| Total Assets | -56.84% | -55.02% | -51.05% | -46.91% | -41.41% |
|
|
|||||
| Total Accounts Payable | 26.81% | 20.06% | 39.24% | 81.46% | 156.36% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -58.86% | -52.36% | -19.82% | -9.27% | 10.29% |
| Total Finance Division Other Current Liabilities | -21.16% | 3.63% | -31.45% | -44.57% | 10.36% |
| Total Other Current Liabilities | -21.16% | 3.63% | -31.45% | -44.57% | 10.36% |
| Total Current Liabilities | 3.93% | 12.19% | 6.16% | 8.42% | 61.72% |
|
|
|||||
| Total Current Liabilities | 3.93% | 12.19% | 6.16% | 8.42% | 61.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -75.32% | 114.10% | -14.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.68% | 9.34% | 5.21% | 8.84% | 60.02% |
|
|
|||||
| Common Stock & APIC | 2.67% | 1.90% | 0.81% | 0.79% | 0.83% |
| Retained Earnings | -22.52% | -26.97% | -29.32% | -32.75% | -37.62% |
| Treasury Stock & Other | -83.51% | 259.29% | 827.27% | 6,831.58% | 243.26% |
| Total Common Equity | -69.16% | -63.96% | -59.52% | -53.09% | -48.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -69.16% | -63.96% | -59.52% | -53.09% | -48.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -69.16% | -63.96% | -59.52% | -53.09% | -48.21% |
|
|
|||||